UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

February 23, 2004
- ------------------
(Date of earliest event reported)


LABORATORY CORPORATION OF AMERICA HOLDINGS
- ------------------------------------------
(Exact name of registrant as specified in its charter)


   DELAWARE                1-11353             13-3757370
 --------------          -----------         --------------
(State or other         (Commission          (IRS Employer
jurisdiction of         File Number)         Identification
incorporation)                                   Number)


358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
- -------------------------------------------------------
(Address of principal executive offices)

336-229-1127
- ------------
(Registrant's telephone number, including area code)

Explanatory Note:
- -----------------
This 8-K/A is furnished to amend in full the Form 8-K furnished on February 24,
2004.

ITEM 9. Regulation FD Disclosure

On February 23, 2004, Laboratory Corporation of America -Registered Trademark-
Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced that Myla Lai-
Goldman, M.D., LabCorp executive vice president, chief scientific officer and
medical director, is scheduled to speak at the Wachovia Securities Cancer
Diagnostics Conference in New York, NY on February 24, 2004 at 9:00 a.m.
Eastern Time. A live audio webcast of the presentation will be available via
the Company web site at www.labcorp.com.  A replay of the audio webcast will be
available through March 24, 2004.



Exhibits:
99.1  Press release of the Company dated February 23, 2004.


SIGNATURES

Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the
undersigned hereunto duly authorized.

          LABORATORY CORPORATION OF AMERICA HOLDINGS
          ------------------------------------------
                        (Registrant)

               By:/s/ BRADFORD T. SMITH
                  ----------------------------------
                      Bradford T. Smith
                      Executive Vice President
                      and Secretary


Date: February 23, 2004

EXHIBIT 99.1

Laboratory Corporation of America-Registered Trademark-Holdings
358 South Main Street
Burlington, NC   27215
Telephone:  (336) 584-5171

For Immediate Release
Contact:  Pamela Sherry - (336) 436-4855
Shareholder Direct: (800) LAB-0401
Company Information: www.LabCorp.com

LABCORP-REGISTERED TRADEMARK-SCHEDULED TO PRESENT AT THE WACHOVIA
SECURITIES CANCER DIAGNOSTICS CONFERENCE

Burlington, NC, February 23, 2004 - Laboratory Corporation of America -
Registered Trademark- Holdings (LabCorp-Registered Trademark-) (NYSE: LH)
today announced that Myla Lai-Goldman, M.D., LabCorp executive vice
president, chief scientific officer and medical director, is scheduled to
speak at the Wachovia Securities Cancer Diagnostics Conference in New York,
NY on February 24, 2004 at 9:00 a.m. Eastern Time. A live audio webcast of
the presentation will be available via the Company web site at
www.LabCorp.com.A replay of the audio webcast will be available through
March 24, 2004.

About LabCorp
Laboratory Corporation of America -Registered Trademark- Holdings is a
pioneer in commercializing new diagnostic technologies and the first in its
industry to embrace genomic testing. With annual revenues of $2.9 billion
in 2003, approximately 23,000 employees nationwide, and more than 220,000
clients, LabCorp offers over 4,400 clinical assays ranging from blood
analyses to HIV and genomic testing. LabCorp combines its expertise in
innovative clinical testing technology with its Centers of Excellence: The
Center for Molecular Biology and Pathology, in Research Triangle Park, NC;
National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories,
Inc. based in Minneapolis, MN; The Center for Esoteric Testing in
Burlington, NC; and DIANON Systems, Inc. based in Stratford, CT.  LabCorp
clients include physicians, government agencies, managed care
organizations, hospitals, clinical labs, and pharmaceutical companies. To
learn more about our growing organization, visit our web site at:
www.LabCorp.com.

Each of the above forward-looking statements is subject to change based on
various important factors, including without limitation, competitive
actions in the marketplace and adverse actions of governmental and other
third-party payors.  Actual results could differ materially from those
suggested by these forward-looking statements. Further information on
potential factors that could affect LabCorp's financial results is included
in the Company's Form 10-K for the year ended December 31, 2002 and will be
included in the Company's form 10-K for the year ended December 31, 2003,
when filed.